search button

The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy

  • Authors:
    • W. Wu
    • H. Kamma
    • E. Ueno
    • M. Fujiwara
    • H. Satoh
    • H. Hara
    • T. Yashiro
    • Y. Aiyoshi

  • View Affiliations

  • Published online on: September 1, 2002     https://doi.org/10.3892/or.9.5.1027
  • Pages: 1027-1031
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Neo-adjuvant chemotherapy has been used for locally advanced breast cancers. With special attention to the proportion of intraductal component, we pathologically studied 25 patients that underwent neo-adjuvant chemotherapy via intra-arterial infusion or intravenous injection. In general, neo-adjuvant chemotherapy had a favorable effect on tumor reduction. The effectiveness varies depending on the predominance of intraductal component. The cases with a high proportion of intraductal component had lower response to the chemotherapies. The larger number of cancer cells remained within the mammary ducts. The residual cancer cells conserved proliferative activity. Intraductal component is poorly responsive to neoadjuvant chemotherapy.

Related Articles

Journal Cover

September-October 2002
Volume 9 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 4.2
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.4
  • CiteScore Rank: Q1: #68/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.786
  • SCImago Journal Rank (SJR): 0.812
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Wu W, Kamma H, Ueno E, Fujiwara M, Satoh H, Hara H, Yashiro T and Aiyoshi Y: The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy. Oncol Rep 9: 1027-1031, 2002
APA
Wu, W., Kamma, H., Ueno, E., Fujiwara, M., Satoh, H., Hara, H. ... Aiyoshi, Y. (2002). The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy. Oncology Reports, 9, 1027-1031. https://doi.org/10.3892/or.9.5.1027
MLA
Wu, W., Kamma, H., Ueno, E., Fujiwara, M., Satoh, H., Hara, H., Yashiro, T., Aiyoshi, Y."The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy". Oncology Reports 9.5 (2002): 1027-1031.
Chicago
Wu, W., Kamma, H., Ueno, E., Fujiwara, M., Satoh, H., Hara, H., Yashiro, T., Aiyoshi, Y."The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy". Oncology Reports 9, no. 5 (2002): 1027-1031. https://doi.org/10.3892/or.9.5.1027